Abstracts

Prenatal HIV Testing Coverage of Medicaid-Insured Women – United States, 2009–2010

Background: Prenatal screening for maternal HIV infection is a critical step in the prevention of mother-to-child transmission of HIV. The U.S. Centers for Disease Control and Prevention (CDC) recommends universal HIV screening of all pregnant women, and since 2006, has recommended an opt-out model to increase HIV testing uptake and coverage. CDC also recommends universal…

Acceptability & Affordability of Self HIV Testing in an Urban Neighborhood With 3% Seroprevalencee

Background: The USFDA recently approved the “OraQuickR In-Home HIV Test,” the first over-the-counter self test for HIV, which retails for approximately US $40. Little is known about the self test’s acceptability, accessibility and affordability in the United States’ most heavily impacted neighborhoods and among individuals at highest risk for acquiring HIV. Methodology: We explored acceptability,…

Availability Accessibility Price of Rapid HIV Self-Tests New York City Pharmacies Summer 2013

Background: The US FDA recently approved an over-the-counter, rapid HIV self-test for personal use. Since October 2012, kits have been available in US pharmacies (manufacturer’s suggested retail price, or MSRP, $39.99). We conducted a survey of NYC pharmacies to assess the availability, accessibility, and price of rapid HIV self-tests. Methodology: All NYC pharmacies (n=2568) were…